Drug recall · November 25, 2015
Meclizine Hydrochloride Tablets recall
Why: Failed Impurities/Degradation Specifications: Out of specification for impurities.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.
- Lots / codes
Lot #: 3060153, Expiry: 08/31/16
- Quantity
- 4,609 Packages
- Company
- Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
- Distribution
- US Nationwide including Puerto Rico
- Initiated
- November 2, 2015 · Voluntary: Firm initiated
- Classified
- November 13, 2015
- Reported
- November 25, 2015
- Ended
- December 21, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Meclizine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.